[F1] Flash Talks (1)

13:41 〜 13:42Infectious Disease Medicine

[F1-02] Development of a Novel Therapeutic Strategy for the Elimination of Hepatitis B Virus DNA Using CRISPR-Cas3

*Yoshiki Saiki¹, Kazuto Yoshimi¹, Masahiko Ito², Tetsuro Suzuki², Yumi Kanegae¹, Tomoji Mashimo¹ (1. Division of Animal Genetics, Laboratory Animal Research Center, Institute of Medical Science , The University of Tokyo (Japan), 2. Department of Microbiology and Immunology, Hamamatsu University School of Me dicine (Japan))

キーワード：

Gene editing、CRISPR-Cas、Hepatitis B virus

閲覧にはパスワードが必要です

ログイン

または